Sands Capital Alternatives, LLC
ARLINGTON, VA · CIK 1846444 · 13F filing filed 2024-08-13
SEC-registered investment adviser since 2011 · limited liability company
- Assets managed$5.4bn
- Staff182 · 66 in investment roles
- Main clients (by assets)Private funds 97%, Pension plans 3%
- Private funds34 · $3.7bn gross assets
- Websitesandscapital.com
- Form ADV · 2026-07-28SEC adviser record
- Legal entitySANDS CAPITAL ALTERNATIVES, LLC (US)
- Kindhedge funds, private equity, venture, futures, wealth
- Others nearbyArlington, VA, London, San Francisco, CA, New York, NY, Charlottesville, VA, Singapore
- FamilySands Capital Alternatives, LLC · 2 related pages
As an employer
- Offices in3 countries
- Private fundsprivate equity 23, venture capital 11
Where they work
Offices
From Form ADV: the main office and the other offices where it does advisory work (at most the 25 largest), with the people doing investment work at each. “About” is worked out: the firm's investment staff less its other offices. Each city links to the other managers there.
| City | People |
|---|---|
| Arlington, VA (main office)United States | about 60 |
| Fitzrovia LondonUnited Kingdom | 2 |
| San Francisco, CAUnited States | 2 |
| New York City, NYUnited States | 1 |
| San Juan, PRUnited States | 1 |
| SingaporeSingapore |
Map: places from GeoNames (CC BY 4.0), outlines from Natural Earth.
Holdings, Q2 2024
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| NU HLDGS LTD NU | $94.5m31.64% | Reduced -1.8m |
| KLAVIYO INC KVYO | $87.5m29.31% | Added +1.3k |
| DOORDASH INC DASH | $46.0m15.41% | Reduced -100.0k |
| UIPATH INC PATH | $14.6m4.91% | Reduced -1.1m |
| SNOWFLAKE INC SNOW | $14.6m4.90% | Reduced -107.3k |
| ACRIVON THERAPEUTICS INC ACRV | $12.3m4.12% | Added +470.0k |
| 10X GENOMICS INC TXG | $9.4m3.14% | Unchanged |
| ACUMEN PHARMACEUTICALS INC ABOS | $8.3m2.77% | Unchanged |
| TARSUS PHARMACEUTICALS INC TARS | $4.6m1.55% | Unchanged |
| CANDEL THERAPEUTICS INC CADL | $2.5m0.84% | Reduced -405.9k |
| TAYSHA GENE THERAPIES INC TSHA | $1.6m0.54% | Unchanged |
| 908 DEVICES INC MASS | $1.2m0.41% | Unchanged |
| SPRUCE BIOSCIENCES INC COM | $409.2k0.14% | Unchanged |
| COUPANG INC CPNG | $250.0k0.08% | Unchanged |
| ABSCI CORPORATION ABSI | $178.0k0.06% | Unchanged |
| SAMSARA INC IOT | $142.9k0.05% | Added +669 |
| DATADOG INC DDOG | $131.6k0.04% | Unchanged |
| TOAST INC TOST | $127.4k0.04% | Reduced -1.0k |
| CROWDSTRIKE HLDGS INC CRWD | $84.7k0.03% | Reduced -58 |
| GITLAB INC GTLB | $32.7k0.01% | Unchanged |
Stakes above 5%
Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.
| Company | Stake |
|---|---|
| ACUMEN PHARMACEUTICALS INC ABOS · 13G · filed 2025-08-13 | 5.6%≈ $9.1m |